 BEVERLY, Mass., Sept. 30, 2021 GLOBE NEWSWIRE -- LexaGene Holdings, Inc., OTCQB: LXXGF; TSX-V: LXG LexaGene or the Company, a commercial molecular diagnostics company selling a point-of-need highly multiplexed in-clinic PCR system with results in approximately two hours, today provided an update on the three veterinary conferences attended by the Company in September. 